Crystal structure of (1-hydroxy-1-phosphono-2-pyridin-3-yl-ethyl)-phos-phonic acid (risedronate), C7H11NO7P2 · H2O, an antiresorptive bones drug

Zeitschrift fur Kristallographie - New Crystal Structures

Volumn 217, Issue JG, 2002, Pages 137-138

  Barbey, C ^a   Lecouvey, M ^a  

^a UNIVERSITÉ PARIS 13   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 23044532484     PISSN: 14337266     EISSN: None     Source Type: Journal    
DOI: 10.1524/ncrs.2002.217.jg.137     Document Type: Article

References (7)

1. Takeuchi, M.; Sakamoto, S.; Kawamuki, K.; Kurihara, H.; Nakahara, H.; Isomura, Y.: Studies on novel bone resorption inhibitors.II. Synthesis and pharmacological activities of fused aza-heteroarylbisphosphonate derivatives. Chem. Pharm. Bull 46 (1998) 1703–1709.
2. Fleisch, H.: Bisphosphonates: Mechanisms of action. Endocrine reviews 19 (1998) 80–100.
3. Russell, R. G.; Rogers M. J.; Frith, J. C.; Luckman, S. P.; Coxon, F. P.; Benford, H.; Croucher, P. I.; Shipman, C.; Fleisch, H. A.: The pharmacology of bisphosphonates and new insights in mechanisms of action. J. Bone Miner Res. 14, Suppl 2 (1999) 53–65.
4. Russell, R. G. G.; Rogers, M. J.: Bisphosphonates: From the laboratory to the clinic and back again. Bone 25 (1999) 97–106.
5. Ebetino, F. H.: The discovery of the Bone-active agent Risedronate, and bisphosphonate structure-activity considerations including the aminophenylethane phosphonate series. Phosphorus, Sulfur and Silicon 144–146 (1999) 9–12.
6. Sheldrick G. M.: SHELXS-90. Program for Solution of Crystal Structures. University of Gottingen, Germany 1990.
7. Sheldrick G. M.: SHELXL-97. A program for refining Crystal Structures. University of Gottingen, Germany 1997.